Financial results - INTER-PHARM SRL

Financial Summary - Inter-Pharm Srl
Unique identification code: 21317835
Registration number: J19/213/2007
Nace: 4120
Sales - Ron
-
Net Profit - Ron
1.266
Employee
8
The most important financial indicators for the company Inter-Pharm Srl - Unique Identification Number 21317835: sales in 2023 was - euro, registering a net profit of 1.266 euro and having an average number of 8 employees. Firma isi desfasoara activitatea in domeniul Lucrari de constructii a cladirilor rezidentiale si nerezidentiale having the NACE code 4120.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Inter-Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - 0 0 - 0 0 0
Total Income - EUR - - - - 0 0 - 0 131.721 96.157
Total Expenses - EUR - - - - 0 0 - 0 83.847 93.811
Gross Profit/Loss - EUR - - - - 0 0 - 0 47.874 2.346
Net Profit/Loss - EUR - - - - 0 0 - 0 46.557 1.266
Employees - - - - 0 0 - 0 7 8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.

Check the financial reports for the company - Inter-Pharm Srl

Rating financiar

Financial Rating -
Inter-Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Inter-Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Inter-Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Inter-Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Inter-Pharm Srl - CUI 21317835

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - 29.968 29.387 - 0 39.328 58.617
Current Assets - - - - 7.840 7.688 - 0 40.395 17.438
Inventories - - - - 0 0 - 0 545 580
Receivables - - - - 7.820 7.668 - 0 0 -13.141
Cash - - - - 20 20 - 0 39.850 29.999
Shareholders Funds - - - - 37.808 37.076 - 0 46.597 47.722
Social Capital - - - - 43 42 - 0 41 40
Debts - - - - 0 0 - 0 33.126 28.333
Income in Advance - - - - 0 0 - 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4120 - 4120"
CAEN Financial Year 4120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 17.438 euro in 2023 which includes Inventories of 580 euro, Receivables of -13.141 euro and cash availability of 29.999 euro.
The company's Equity was valued at 47.722 euro, while total Liabilities amounted to 28.333 euro. Equity increased by 1.266 euro, from 46.597 euro in 2022, to 47.722 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Inter-Pharm Srl

Comments - Inter-Pharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.